🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10378058

Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer

The Board of Regents of the University of Texas System · Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10369103

Neuroprotective liposome compositions and methods for treatment of stroke

The Board of Regents of the University of Texas System · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10370360

Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10363319

Glycoconjugates and methods for their use

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10363248

Salts of heterocyclic modulators of HIF activity for treatment of disease

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10363261

Enolase inhibitors and methods of treatment therewith

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10363311

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10363245

Methods for treating CNS lesions

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10357464

Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief

The Board of Regents of the University of Texas System · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10358419

1,3-dipolar [70]fulleropyrrolidinium iodide derivatives

The Board of Regents of the University of Texas System · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10358439

DNA binding agents with a minor groove binding tail

The Board of Regents of the University of Texas System · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10358501

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

The Board of Regents of the University of Texas System · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10357448

Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding

The Board of Regents of the University of Texas System · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10351522

Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof

The Board of Regents of the University of Texas System · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10342822

Method of producing physiological and therapeutic levels of nitric oxide through an oral d

The Board of Regents of the University of Texas System · Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10344025

GLS1 inhibitors for treating disease

The Board of Regents of the University of Texas System · Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10345310

Diagnostic test for early stage cancer

The Board of Regents of the University of Texas System · Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335476

Vaccine to protect against Ehrlichia infection

The Board of Regents of the University of Texas System · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10336786

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

The Board of Regents of the University of Texas System · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335470

Immunogenic compositions comprising progastrin and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335382

Use of hydrogen sulfide synthesis inhibitors for cancer therapy

The Board of Regents of the University of Texas System · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10329353

Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating

The Board of Regents of the University of Texas System · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10330600

Plasmonic-magnetic bifunctional nanotubes for biological applications

The Board of Regents of the University of Texas System · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10328139

Live-attenuated vaccine against plague

The Board of Regents of the University of Texas System · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted